The Effect of Multidomain Dietary Education in Type 2 Diabetic Adults

Sponsor
National Kaohsiung Normal University (Other)
Overall Status
Completed
CT.gov ID
NCT05892861
Collaborator
National Cheng-Kung University Hospital (Other)
40
1
2
21.9
1.8

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to [learn about cognitive stimulation by multidomain dietary education including the dietary board game via LINE in non-dementic type 2 diabetic adults. The main questions it aims to answer are:

[Question 1: Could multi-domain dietary education as cognitive stimulation improve cognitive function?] [Question 2: Could multi-domain dietary education improve dietary control belief ?] [Question 3: Could multi-domain dietary education improve health behavior?] [Question 4]: Could multi-domain dietary education improve HbA1C, and lipid profile? Participants of experimental A group will receive a video about lifestyle education 5 minutes weekly for 3 weeks, a dietary board game 10 minutes weekly for 10 weeks, and a 24-hour dietary recall record 2 times weekly for 7 weeks. And participants of the experimental B group receive the usual clinical treatment. Then experimental A and Experimental B groups will cross over 12 weeks later.

Researchers will compare the effect of intervention between the experimental A group and the experimental B group.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: cognitive stimulation
  • Other: as usual care
N/A

Detailed Description

Cognitive function was measured by the Saint Louis University Mental State (SLUMS) score. And we exclude the dementia group according to the SLUMS definition (<21 if the participants graduated from senior high school or above, <20 if the education level below senior high school).

Experimental group A received 10-week curriculum from 1st week to 10th week, and receive d usual clinical care from 13th week to 22th week. Experimental B group received usual clinical care from 1st week to 10th week, and received 10-week curriculum from 13th week to 22th week.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effect of Multidomain Dietary Education in Type 2 Diabetic Adults
Actual Study Start Date :
Jun 3, 2021
Actual Primary Completion Date :
Dec 31, 2022
Actual Study Completion Date :
Mar 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: multi domain dietary education as cognitive stimulation

video lifestyle education, board game, and 24-hour dietary recall record from 1st week to 10th week as cognitive stimulation.

Behavioral: cognitive stimulation
video education, board games, and 24-hour dietary recall record

Experimental: usual clinical treatment

usual treatment in clinic

Other: as usual care
history taking, explain data, and discuss how to control healthy condition

Outcome Measures

Primary Outcome Measures

  1. The change of cognitive function from baseline at 3 and 6 months [12th week & 24 week]

    Saint Louis University Mental State examination, the total score range is 0~30. Higher scores mean better change.

Secondary Outcome Measures

  1. The change of dietary control belief from baseline at 3 and 6 months [12th week and 24th week]

    12 questions by Linkert scale (4 questions about dietary mastery items and 8 questions about dietary perceived constraints items) about dietary control belief(the total score range is 12 to 60) Higher scores mean better change.

Other Outcome Measures

  1. The change of the awareness of complication and health behavior from baseline at 3 and 6 months [12th week and 24th week]

    8 questions about the complications of type 2 DM (stroke, blind, wood healing, amputation, CKD, CAD, hypoglycemia, and Dementia) by Linkert scale (the total score range is 8 to 40). Higher scores mean better change.

  2. The change of HbA1C from baseline at 3 and 6 months [12th week and 24th week]

    biomedical data after phlebotomy (HbA1C in %), Higher scores mean worse change.

  3. The change of total cholesterol from baseline at 3 and 6 months [12th week and 24th week]

    biomedical data after phlebotomy (total cholesterol in mg/dl). Higher scores mean worse change.

  4. The change of triglyceride from baseline at 3 and 6 months [12th week and 24th week]

    biomedical data after phlebotomy (triglyceride in mg/dl). Higher scores mean worse change.

  5. The change of low-density lipoprotein cholesterol from baseline at 3 and 6 months [12th week and 24th week]

    biomedical data after phlebotomy (low-density lipoprotein cholesterol in mg/dl). Higher scores mean worse change.

  6. The change of high-density lipoprotein cholesterol from baseline at 3 and 6 months [12th week and 24th week]

    biomedical data after phlebotomy (high-density lipoprotein cholesterol in mg/dl). Higher scores mean worse change.

  7. The change of health behavior awareness from baseline at 3 and 6 months [12th week and 24th week]

    9 questions about health behavior (body weight measurement, foot care, blood pressure measurement, drug adherence, diet adherence, calculation of intake amount by hand when eating, smoking habits, drinking habits, and exercise habits) by Linkert scale (total score range is 9 to 45). Higher scores mean better change.

  8. The change of health behavior frequency per week from baseline at 3 and 6 months [12th week and 24th week]

    9 questions about health behavior (body weight measurement, foot care, blood pressure measurement, drug adherence, diet adherence, calculation of intake amount by hand when eating, smoking habits, drinking habits, and exercise habits) by Linkert scale (total score range is 9 to 45). Higher scores mean better change.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • The onset age of Diabetes Mellitus is more than 20 years old

  • Diagnosis of Diabetes according to past history including type 2 diabetes mellitus or drug history including oral anti-diabetic drugs

Exclusion Criteria:
  • SLUMS meets the Dementia definition.

  • HbA1C ≥ 10.0%

  • Rejected our study.

  • History of stroke.

  • History of depression.

  • History of psychiatric disease.

  • Visual impairment.

  • Hearing impairment.

  • Can't understand the informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Yong-Kang Clinic Kaohsiung Taiwan

Sponsors and Collaborators

  • National Kaohsiung Normal University
  • National Cheng-Kung University Hospital

Investigators

  • Principal Investigator: Ling-Chun Ou, National Kaohsiung Normal University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ou Ling-Chun, Principal Investigator, National Kaohsiung Normal University
ClinicalTrials.gov Identifier:
NCT05892861
Other Study ID Numbers:
  • 21-065-B
First Posted:
Jun 7, 2023
Last Update Posted:
Jun 12, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 12, 2023